Canada markets closed

Ionis Pharmaceuticals, Inc. (0JDI.L)

LSE - LSE Delayed Price. Currency in USD
Add to watchlist
47.37-0.05 (-0.11%)
At close: 07:13PM BST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.35
52-Week Change 319.66%
S&P500 52-Week Change 322.55%
52 Week High 353.94
52 Week Low 333.21
50-Day Moving Average 348.72
200-Day Moving Average 344.34

Share Statistics

Avg Vol (3 month) 3351
Avg Vol (10 day) 3342
Shares Outstanding 5137.57M
Implied Shares Outstanding 6N/A
Float 8144.72M
% Held by Insiders 10.87%
% Held by Institutions 1100.45%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -49.54%
Operating Margin (ttm)-125.12%

Management Effectiveness

Return on Assets (ttm)-8.13%
Return on Equity (ttm)-98.27%

Income Statement

Revenue (ttm)776.62M
Revenue Per Share (ttm)5.40
Quarterly Revenue Growth (yoy)-8.40%
Gross Profit (ttm)N/A
EBITDA -354.61M
Net Income Avi to Common (ttm)-384.77M
Diluted EPS (ttm)-0.03
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.21B
Total Cash Per Share (mrq)15.17
Total Debt (mrq)1.98B
Total Debt/Equity (mrq)667.43%
Current Ratio (mrq)7.37
Book Value Per Share (mrq)2.03

Cash Flow Statement

Operating Cash Flow (ttm)-323.46M
Levered Free Cash Flow (ttm)-156.68M